Article
Requirements for ICAM-1 immunogene therapy of lymphoma.
Cancer gene therapy - 1 Jun 2003
Kanwar Jagat R, Berg Randy W, Yang Yi, Kanwar Rupinder K, Ching Lai Ming, Sun Xueying, Krissansen Geoffrey W
Abstract excerpt
Intercellular cell adhesion molecule-1 (ICAM-1) is a cell-surface glycoprotein capable of eliciting bidirectional signals that activate signalling pathways in leukocytes, endothelial, and smooth muscle cells. Gene transfer of xenogeneic ICAM-1 into EL-4 lymphomas causes complete tumor rejection; however, it is unknown whether the mechanism responsible involves the "foreignness" of the ICAM-1 transgene,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
